comprehensive -WSS

comprehensive

author：focus 2025-09-03 09:25:41 - browse：3

Portrait of R. Shawn Martin -- health coverage from STAT — R. Shawn Martin, the CEO of the American Academy of Family Physicians Courtesy American Academy of Family Physicians

In ten years, the United States could be short as many as 48,000 primary care doctors. The specialty is underpaid, to a point that doctors are lobbying Medicare to pay it extra. Even medical residents who chose the specialty are leaving primary care; some 45% of residents who planned to be generalists changed their mind during their residencies.

But R. Shawn Martin, the CEO of the American Academy of Family Physicians, the specialty trade group, isn’t worried.

“I’ve been around this and at this a long time and family medicine and primary care’s obituary has been written many times in my 25-plus years of doing this work,” he said with a laugh. “This isn’t the first time that primary care has been dying or fading away.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Protect nursing home residents from future pandemics

WSS

Cancer diagnosis changes perspective doctor, former hospital CEO

Stroke rates rising, especially in working

Carbon Health diabetes program, a test of data

Hospitals need to get ahead of regulations on climate change

Should insurance cover cosmetic surgery?

A letter from the executive editor: STAT UnitedHealth investigation

focus

comprehensive

knowledge

As demand for Covid shots wanes, Moderna seeks its next success

The HPV vaccine prevents cancer in men, too. Why do so few people get it?

Sports medicine is finally prioritizing gender equality

Bubonic plague hit France in 1720. Officials dithered. Sound familiar?

BioMarin wins approval for gene therapy to treat hemophilia A

Cancer diagnosis changes perspective doctor, former hospital CEO

Jerome Adams on the need for new antivirals for Covid

Eli Lilly’s chief scientist on obesity drugs, gene editing, and more

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Carbon Health diabetes program, a test of data

focus

Readout Newsletter: Ozempic panic wanes, Legend x Novartis, etc.

Eli Lilly’s chief scientist on obesity drugs, gene editing, and more

A letter from the executive editor: STAT UnitedHealth investigation

Medical students need to learn the potent medicine of empathy

Lawsuit challenges CMS nursing home minimum staffing rule

Type 2 diabetes prevention programs work at large scale: study

hotspot

knowledge

hotspot

focus